Abortion pill ruling: A federal judge in Texas halts FDA's approval of mifepristone, an abortion medication. But another judge contradicts the ruling.

Texas abortion pill ruling threatens FDA ‘This opens the door to the courts’ second-guessing any FDA approval — especially for drugs for controversial areas like gender-affirming care ...

A federal judge in Texas issued a ruling Friday on the medication abortion drug mifepristone, saying he will suspend the FDA’s two-decade-old approval – but paused his ruling for seven days so ...

In Texas, U.S. District Judge Matthew Kacsmaryk ruled that the Food and Drug Administration improperly approved the abortion pill mifepristone more than 20 years ago.

The Texas lawsuit targeted the FDA’s loosening of restrictions on the abortion pill, including the agency’s decision in 2016 to say the drug could be used through 10 weeks of pregnancy, ...

The FDA did not respond to that petition until 2016, rejecting it on the same day that the agency relaxed restrictions on the medication, citing its safety, efficacy and minuscule rate of adverse ...

Federal judges issue conflicting rulings over FDA's approval of abortion pill mifepristone 02:39. Washington — A federal judge in Texas on Friday halted the Food and Drug Administration's ...

A Texas federal judge ruled Friday evening to suspend the FDA’s approval of mifepristone — one of two drugs used together to cause an abortion — virtually banning the sale of the pills ...

In July 2015, the FDA detained 1,000 vials of sodium thiopental meant for the Texas Department of Criminal Justice. Sodium thiopental, which also is referred to as ‘thiopental,’ is an anesthetic.

A federal judge in Texas has thrown into jeopardy the most common method of abortion in the U.S., ordering regulators to temporarily halt their approval of the drug mifepristone for abortion.

The federal government will now send a first shipment of more than a million doses destined for children in that age group to providers in nearly half of the state's counties.

The Sugar Land company involved in Gov. Rick Perry's unlicensed adult stem-cell procedure is rife with basic manufacturing problems, according to the U.S. Food and Drug Administration. In a report ...